BCL2 and lymphoma: In a series of experiments using human lymphoma cell lines, RNAi-mediated depletion of Crebbp on a VavP-BCL2 background and GC-specific conditional Crebbp knockout, two independent groups recently demonstrated that CREBBP loss promotes the development of GC-derived lymphomas in vivo (51, 109).